BRD7 Antikörper (C-Term)
-
- Target Alle BRD7 Antikörper anzeigen
- BRD7 (Bromodomain Containing 7 (BRD7))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BRD7 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- Purified
- Immunogen
- BRD7 antibody was raised in rabbit using the C terminal of BRD7 as the immunogen
- Top Product
- Discover our top product BRD7 Primärantikörper
-
-
- Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
BRD7 Blocking Peptide, catalog no. 33R-4343, is also available for use as a blocking control in assays to test for specificity of this BRD7 antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Konzentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Target
- BRD7 (Bromodomain Containing 7 (BRD7))
- Andere Bezeichnung
- BRD7 (BRD7 Produkte)
- Synonyme
- zgc:66347 antikoerper, wu:fc95f02 antikoerper, MGC79478 antikoerper, BRD7 antikoerper, BP75 antikoerper, CELTIX1 antikoerper, NAG4 antikoerper, Ptpn13ip antikoerper, bromodomain containing 7 L homeolog antikoerper, bromodomain containing 7 antikoerper, brd7.L antikoerper, brd7 antikoerper, BRD7 antikoerper, Brd7 antikoerper
- Hintergrund
- BRD7 is an activator of the Wnt signaling pathway in a DVL1-dependent manner by negatively regulating the GSK3B phosphotransferase activity. It induces dephosphorylation of GSK3B at 'Tyr-216'. Synonyms: Polyclonal BRD7 antibody, Anti-BRD7 antibody, bromodomain containing 7 antibody, BP75 antibody, CELTIX1 antibody, NAG4 antibody.
-